CD44 and Alzheimer disease: This suggested that neuroinflammation pathology involving LCK, ZAP70, and CD44 would affect MAPT more than APP. Further investigation is required to elucidate the mechanistic interactions responsible for the effect of MAPT and hub genes in AD pathogenesis.